KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Clover Health Investments (CLOV) Shares Repurchased (2021 - 2025)

Clover Health Investments' Shares Repurchased history spans 5 years, with the latest figure at $1000.0 for Q3 2025.

  • For Q3 2025, Shares Repurchased changed N/A year-over-year to $1000.0; the TTM value through Dec 2025 reached $18.3 million, up 932.62%, while the annual FY2025 figure was $18.3 million, 932.62% up from the prior year.
  • Shares Repurchased reached $1000.0 in Q3 2025 per CLOV's latest filing, down from $18.3 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $18.3 million in Q1 2025 to a low of -$6.3 million in Q4 2022.
  • Average Shares Repurchased over 5 years is $2.0 million, with a median of $211500.0 recorded in 2021.
  • Peak YoY movement for Shares Repurchased: plummeted 2940.0% in 2023, then surged 159.42% in 2024.
  • A 5-year view of Shares Repurchased shows it stood at $147000.0 in 2021, then crashed by 4399.32% to -$6.3 million in 2022, then surged by 52.82% to -$3.0 million in 2023, then soared by 159.42% to $1.8 million in 2024, then tumbled by 99.94% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Shares Repurchased are $1000.0 (Q3 2025), $18.3 million (Q1 2025), and $1.8 million (Q2 2024).